Physician profile
Diana E White
NPI 1154920668
$11,336.65
in general payments reported to CMS, 2019-2025
31 companies · $3,019 in 2025
The $3,019 reported for 2025 was more than what 97% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,704 · 2022: $2,053 · 2023: $2,316 · 2024: $2,245 · 2025: $3,019.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,206 · Travel and Lodging: $374.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,205.82 |
| Travel and Lodging | $373.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,923.81 | 2021-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $1,381.67 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $1,329.61 | 2021-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $1,118.28 | 2021-2025 | Farxiga, Airsupra, Brilinta |
| Abbott Laboratories | $899.14 | 2024-2025 | Cardiomems |
| Bayer Healthcare Pharmaceuticals INC. | $721.66 | 2022-2025 | |
| Novo Nordisk INC | $719.90 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Esperion Therapeutics, INC. | $680.72 | 2021-2025 | Nexletol, Nexlizet |
| Inari Medical, INC. | $543.23 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Merck Sharp & Dohme LLC | $517.95 | 2022-2025 | Verquvo, Capvaxive |
| Boehringer Ingelheim Pharmaceuticals, INC. | $238.30 | 2021-2024 | Jardiance |
| Abiomed | $173.49 | 2024 | Impella |
| Pfizer INC. | $149.71 | 2023-2025 | |
| Boston Scientific Corporation | $139.46 | 2021-2025 | Bodyguardian |
| Cvrx, INC. | $129.97 | 2023 | Barostim Neo System |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $124.99 | 2024 | Amvuttra |
| Agepha Pharma Fz LLC | $73.50 | 2024 | Lodoco |
| Amarin Pharma, INC. | $71.27 | 2021-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $59.16 | 2021-2024 | Lifevest |
| Scpharmaceuticals INC. | $54.69 | 2023-2024 | |
| Daiichi Sankyo INC. | $49.85 | 2023 | Injectafer |
| Atricure, INC. | $46.84 | 2023 | |
| Sanofi-Aventis U.S. LLC | $32.18 | 2022-2023 | |
| E.R. Squibb & Sons, L.L.C. | $31.23 | 2024 | Eliquis |
| Actelion Pharmaceuticals US, INC. | $26.03 | 2025 | Opsumit, Uptravi |
| Althera Pharmaceuticals LLC | $23.57 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $20.67 | 2024 | |
| Xeris Pharmaceuticals, INC. | $17.80 | 2025 | Keveyis |
| Heartflow, INC. | $13.53 | 2025 | |
| Kiniksa Pharmaceuticals, LTD. | $13.19 | 2023 | Arcalyst |
| Alexion Pharmaceuticals, INC. | $11.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diana White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.